Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I love your “take” Bio and am now left wondering does this mention by CNBC mean anything for tomorrow’s open or portend a positively volatile week for AVXL? Enquirin’ minds are left to wonder.
Wrong. Follow the science which is the bedrock that BlackRock finds attractive and worthwhile investing in.
Ease of trade execution and have never had any issues. The phone app works well too. Feel free to get other opinions and features discussed as my experience is somewhat limited.
I like Fidelity for stocks and Tastyworks for Options
It’s more like interest in your posts here are drying up....about to be irrelevant. Imagine if you will deep fried calamari with a generous lemon squeeze...mmmm delicious!
Tasty works dot com
Two words: Poison Pill
It’s most likely the lasers in space zapping Anavex’s share price...all cabal controlled. Fortunately they were out of commission yesterday.
Me too Investor2014!
A Bull here too.
Speculation is for amateurs.
Well stated TempePhil. We all suspect that there are nefarious forces afoot here, and plausible deniability as it pertains to the importance of Anavex’s ongoing trials is right out of their playbook.
But Doc, tell me which one of these two drugs does she actually want to take for herself? I think you know the answer, and it’s Anavex’s A2-73.
Bingo! You nailed it nidan7500. Have you ever been really sick or incapacitated in some way? When your health or mobility returns, you can properly appreciate the value in that sense of well being.
I agree mrplmer!
While I don’t always agree with Xena on all topics, I know that her heart’s in the right place and I admire her passion and fierce devotion to the promotion of truth and science as it pertains to Anavex Life Sciences. I’m ultimately in her corner and hope that Anavex’s data, trials, and events bring an end to suffering for the afflicted in 2021 and a corresponding spike in share price for those funding this collection of CNS trials.
Yes, that’s a great strategy basparks79 and helps to separate the FUD (we know who you are) from the meaningful posts, that actually offer industry insight and information of value.
I agree, it makes no sense and won’t be happening.
I couldn’t agree more Talon38, as Anavex’s pipeline will indeed be at Keytruda levels over time. Hold on Longs!!!!!
And what’s the percentage of humans with the wild type gene again? Was it the 80-84% figure?
And a giant douche.
Love your analysis and take down of Biogen and the poor choices made by suits in high places who are supposed to provide a vision and forward guidance. Biogen shareholders are not getting their money’s worth. Anyway, it’s nice to see that Anavex’s careful and relentless path forward despite the many obstacles, has been data driven development and disclosure on a time frame dependent upon the science and not the market. Compromises made now to assuage anxious investors, could jeopardize a positive future outcome and Missling is masterfully walking that fine line to appease the needs of all parties.
You know nothing mike. The market is looking for a quick hit or miss on a day like yesterday’s. If they don’t hear certain superlative catch phrases or assurances they move on ie. not digesting the truth within the difficult data and it’s forward looking ramifications for the CNS disease spectrum.
Agreed. It paints a very different picture than Doc’s predictably negative reviews. The truth lies somewhere in between but I think this analysis is closer to the truth.
Sure, an injectable drug with only limited use and with detrimental side effects...laughable comment and not yet approved.
Well stated Tradeherpete! Anavex long and strong here!
Agreed!
80-84%
Better patent protection may be the answer.
Clever comment but too premature.
I enjoyed that comment Mr. Palmer!
I agree XenaLives...
KEY TAKEAWAYS:
1) An NDA acknowledges a confidential relationship between two or more parties and protects the information they share from disclosure to outsiders.
2) The NDA is common before discussions between businesses about potential joint ventures.
3) Employees are often required to sign NDAs to protect an employer's confidential business information.
We know it isn’t a simple question.
False.
“Reduced cost” is a vague term so Anavex doesn’t necessarily have to give it away.
Exactly. Those little dots you see are bits of gun powder about to be lit up..........!
I agree.
Perfectly stated basparks79! Missling is a man of integrity.
I agree JWC3.
Merck teams up with Yumanity in neurodegenerative diseases https://seekingalpha.com/news/3585638-merck-teams-up-yumanity-in-neurodegenerative-diseases